Abbott Laboratories (ABT.N) reported slightly better-than-expected quarterly earnings on strong sales of branded and generic medicines and medical devices. The company earned $864 million, or 55 cents per share, in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott earnings narrowly beat forecasts
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account